financetom
Business
financetom
/
Business
/
Nike Stock Sprints Higher After The Bell As Bill Ackman's Pershing Square Reveals New Stake
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nike Stock Sprints Higher After The Bell As Bill Ackman's Pershing Square Reveals New Stake
Aug 14, 2024 2:30 PM

Nike Inc ( NKE ) shares are trading higher in Wednesday’s after-hours session after hedge fund Pershing Square disclosed a new position in the iconic athletic footwear and apparel brand.

What Happened: According to a new 13F filing with the U.S. Securities and Exchange Commission released after the market close on Wednesday, Bill Ackman’s Pershing Square purchased a new stake in Nike ( NKE ) during the second quarter.

Pershing Square now owns approximately 3.04 million shares of Nike ( NKE ), worth approximately $230 million as of Wednesday’s close. Nike ( NKE ) shares were up 4.88% in after-hours trading at the time of writing, according to Benzinga Pro.

The Pershing Square filing comes after analysts at Gordon Haskett suggested that Nike ( NKE ) could be the next target for activist investors after Starbucks Corp ( SBUX ) shares surged on a CEO change earlier this week.

According to Benzinga Pro, traders were circling an unconfirmed report on Wednesday suggesting activists were pushing for former Deckers CEO Dave Powers to take over at Nike ( NKE ). Powers officially retired from Deckers on Aug. 1.

Pershing Square previously invested in Nike ( NKE ) in 2017, but the firm sold its stake about six months later, locking in a quick $100 million in profit, per CNBC.

See Also: Nike’s Options: A Look at What the Big Money is Thinking

NKE Price Action: Nike ( NKE ) shares are down about 27% year-to-date. The stock was up 4.92% at $82.38 at the time of publication Wednesday, per Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: US Antitrust Regulator Seeking Details on Amazon's Deal With AI Firm Adept
Update: Market Chatter: US Antitrust Regulator Seeking Details on Amazon's Deal With AI Firm Adept
Jul 16, 2024
10:50 AM EDT, 07/16/2024 (MT Newswires) -- (Updates with Amazon ( AMZN ) declining to comment in the fourth paragraph.) The US Federal Trade Commission is asking Amazon.com ( AMZN ) for details on a deal to hire senior executives from artificial intelligence company Adept, Reuters reported Tuesday, citing an unnamed source familiar with the matter. On June 28, Adept...
Powerschool Holdings Insider Sold Shares Worth $657,292, According to a Recent SEC Filing
Powerschool Holdings Insider Sold Shares Worth $657,292, According to a Recent SEC Filing
Jul 16, 2024
10:57 AM EDT, 07/16/2024 (MT Newswires) -- Eric Ryan Shander, President, CFO, on July 11, 2024, sold 29,200 shares in Powerschool Holdings ( PWSC ) for $657,292. Following the Form 4 filing with the SEC, Shander has control over a total of 425,524 shares of the company, with 425,524 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1835681/000183568124000093/xslF345X03/wk-form4_1721140849.xml Price: 22.51, Change: +0.04, Percent...
Vertex Pharmaceuticals, Genomics Extend Drug Discovery, Development Collaboration by 3 Years
Vertex Pharmaceuticals, Genomics Extend Drug Discovery, Development Collaboration by 3 Years
Jul 16, 2024
10:56 AM EDT, 07/16/2024 (MT Newswires) -- Vertex Pharmaceuticals ( VRTX ) and Genomics are extending their collaboration by three years to discover and develop precision medicines using genetics and machine learning, Genomics said Tuesday. The collaboration, which started in 2018 and was previously extended in 2021, will now continue until 2026, according to Genomics. The company also said it...
Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?
Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?
Jul 16, 2024
Silo Pharma Inc ( SILO ) shares are trading higher on Tuesday on a high session volume of over 87 million. The company entered into an exclusive global license agreement to further develop, manufacture, and commercialize its Alzheimer’s drug SPC-14. Silo intends to utilize the FDA’s streamlined 505(b)(2) pathway for SPC-14, which would shorten clinical timelines and reduce drug development...
Copyright 2023-2026 - www.financetom.com All Rights Reserved